Our website uses cookies to make navigation as functional as possible and to perform statistics on its usage. Should you wish to receive more information, or deny your consent to all or some of the cookies, please click here. By continuing to browse this website, you will be accepting our cookies.
Menu

VitaPCRTM platform

TheVitaPCRTM Instrument is a rapid molecular POCT platform utilizing a real-time reverse transcription polymerase chain reaction (RT-PCR) amplification technology for the processing and analysis of VitaPCRTM tests.

The VitaPCRTM SARS-CoV-2 Assay, performed on the VitaPCRTM Instrument, is a rapid molecular in vitro diagnostic test utilizing a real-time reverse transcription polymerase chain reaction (RT-PCR) amplification technology. It is used for the qualitative detection and discrimination of SARS-CoV-2 viral RNAs in direct nasopharyngeal (NP) or oropharyngeal (OP) swabs from patients with signs and symptoms of respiratory infection who are suspected of COVID-19. The test allows the detection of SARS-CoV-2 in apporximately 20 minutes.


The VitaPCRTM Flu A&B
Assay also available for the use with the VitaPCRTM Instrument, is a rapid molecular in vitro diagnostic test utilizing a real-time reverse transcription polymerase chain reaction (RT-PCR) amplification technology for the qualitative detection and discrimination of influenza A and B viral RNA in nasal and nasopharyngeal swabs from patients with signs and symptoms of respiratory infection.


Real Time PCR SARS-CoV-2 Assay

EASY

  • Simple 1min hands-on time preparation
  • Minimal training required for operation
  • Automated result interpretation

RAPID

  • Sample to result in 20min
  • Process more samples in less time
  • Improved patient management and triage

VERSATILE

  • Can be deployed anywhere
  • No additional equipment needed
  • Room temperature storage – tests ready for use


Catalog No. Qty Description
51572 1 VitaPCR™ Instrument
51574 20 VitaPCR™ SARS-CoV-2 assay
51573 20 VitaPCR™ Flu A&B assay


GENERAL DIAGNOSTIC PROCEDURE

RESULT INTERPRETATION


For more information, visit www.credodxbiomed.com